PBYI US EQUITY Health Care Health Care CIK: 1401667

PUMA BIOTECHNOLOGY, INC. (PBYI) Quant Factor Diagnostic & Fair Value Model

PUMA BIOTECHNOLOGY, INC. (Ticker: PBYI) is listed in the Health Care sector (Health Care). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.

$11.02
-2.13% Latest Close (2026-10-23)
Market Cap: $581.24M
P/E Ratio: 22.1
Momentum Strength 3M / 12M
+37.92%
1M: +12.22% 12M: 0.00%
Quality (ROE) Point-in-Time
-
Trailing Return on Equity
Technical Trend RSI 14
67.3
SMA50: $9.66 SMA200: $8.88
Valuation Multiplier Trailing
22.1
Moderate Valuation Corridor (15x - 30x P/E)
📊 Valuation & Multi-Factor Diagnostic
Moderate Valuation Corridor (15x - 30x P/E)

PBYI trades within a typical sector multiple band (22.1x P/E), broadly aligned with trailing earnings.

⚡ Benchmark Factor Strategy
S&P 500 Momentum Alpha Strategy
This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.

📈 Daily Candlestick & Volume Quant Chart

Interactive lightweight price action & volume breakdown over recent 90 trading days.

均线多头 (MA20/50) Piotroski F-Score: 4/9 (Moderate Financial Health)

Official Point-in-Time Financial Filing History

Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.

备案 CIK: 1401667 · 10-K 年报 / 10-Q 季报
Form Period End Filing Timestamp (Point-in-Time) Revenue Net Income Operating CF EPS (Diluted)
No point-in-time filings synced yet. Automated batch scheduler will align CIK: 1401667

💡 Methodology & Frequently Asked Questions

Key reference details regarding PUMA BIOTECHNOLOGY, INC. (PBYI) valuation multiples, momentum factors, and point-in-time filing conventions.

How should PBYI's current valuation multiple be interpreted? ↓
PBYI trades at a trailing P/E of 22.1x within the Health Care sector (moderate valuation corridor (15x - 30x p/e)). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.
What are PBYI's key momentum and technical factor indicators? ↓
As of the latest close, PBYI shows a 1-month return of +12.22%, 3-month return of +37.92%, and 12-month return of 0.00%, with a 14-day RSI of 67.3. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.
What is Point-in-Time (PIT) financial data and why does it matter for PBYI? ↓
Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.
How can PBYI be incorporated into systematic factor models? ↓
PBYI can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.

Related Peers & Valuation Comparison in Health Care

Dense Internal Network Mesh